Introduction
An intricate network of biochemical repair systems operates in cells to protect DNA from deleterious accumulation of DNA damage and permanent mutations. One of the most important and best studied repair processes in prokaryotes and eukaryotes is the nucleotide excision repair pathway (reviewed by Friedberg, 1985) . This system removes a broad range of lesions caused by very dissimilar agents such as UV-induced photoproducts (cyclobutane and 8-4 pyrimidine dimers, thymine glycols), bulky chemical adducts, and cross-links. It is thought to sense t Present address: Department of Cell Biology and Genetics, Erasmus University, 3000 DR Rotterdam, The Netherlands.
general distortions in the regular helical conformation of DNA (e.g., kinks and bends). A detailed insight into the molecular mechanism of this process has emerged from the work on Escherichia coli (reviewed by Sancar and Sancar, 1988; Grossman et al., 1988) . In this organism at least six proteins participate in this pathway, including the SOS-induced uvrAB helicase complex that scans the DNA for structural abnormalities and the uvrC endonuclease that incises the damaged strand on both sides of the lesions.
Little is known about the way the nucleotide excision machinery acts in eukaryotes. In the yeast Saccharomyces cerevisiae, mutant analysis and gene cloning have revealed the existence of at least ten genetic loci collectively designated as the RAD3 epistasis group (Friedberg, 1988; Haynes and Kunz, 1981) . Two classes of excision repairdefective cell lines can be discerned within mammals. The first comprises cells from patients suffering from the autosomal-recessive human repair disorder xeroderma pigmentosum (XP). This rare, cancer-prone syndrome is clinically characterized by extreme sensitivity of the skin to sunlight (UV) exposure, pigmentation abnormalities, predisposition to skin cancer, and, frequently, neurological degeneration (Cleaver and Kraemer, 1989) . The molecular defect in most XP patients resides in early steps of the excision repair pathway. Genetic complementation analysis by cell fusion has revealed the existence of eight complementation groups, designated XP-A through XP-H. (Recently, the status of complementation group XP-H has been challenged [Johnson et al., 1989; Robbins, 1989; Johnson, 1989; our unpublished data] .) Interestingly, two patients belonging to distinct XP complementation groups, XP-B and XP-H, have been found to exhibit the clinical symptoms of both XP and another rare excision repair disorder, Cockayne's syndrome (CS) (reviewed by Lehmann, 1987) .
The second class of mammalian repair mutants is represented by the laboratory-induced UV-sensitive rodent (mainly Chinese hamster ovary [CHO] ) cell lines, among which eight complementation groups have been thus far identified (reviewed by Collins and Johnson, 1987; Busch et al., 1989) . It is unlikely that with these sets of mutant cells all the mammalian repair functions are represented. Complementation tests between the rodent and XP mutants-although far from complete-have thus far not revealed any overlap between these two classes of repairdeficient cells (Thompson et al., 1985; Stefanini et al., 1985; van Duin et al., 1989) . These findings suggest the involvement of a substantial number of genes in excision repair and a considerable complexity at the biochemical level.
The rodent mutants have proven to be very valuable for the isolation of correcting human genes, designated excision repair cross-complementing rodent repair deficiency (ERCC) genes. DNA-mediated gene transfer has led to the cloning of the ERCC-7 and ERCC-2 genes, correcting CHO mutants belonging to complementation groups 1 and 2, respectively (Westerveld et al., 1984; Weber et al., 1988) . Analysis of these genes has revealed a striking evolutionary sequence conservation at the protein level. The ERCC-7 gene product is homologous to the yeast RADlO repair protein and to parts of the E. coli uvrA and uvrC polypeptides (van Duin et al., 1988; Hoeijmakers et al., 1988; Doolittle et al., 1988) . The ERCC-2 gene was found to be the human counterpart of the yeast repair gene RAD3 (Weber et al., 1990) which encodes a 5'+3' DNA helicase (Sung et al., 1987a (Sung et al., , 1987b . In addition, the mouse gene correcting SV40-transformed XP-A fibroblasts has been cloned after extensive genomic DNA transfection experiments (Tanaka et al., 1989) . The cloning of other XP genes is being attempted (Arrand et al., 1989; Teitz et al., 1987) . Recently, we have cloned the ERCC-3 gene, correcting CHO mutants belonging to group 3 (Weeda et al., 1990 ). Here we report the cDNA cloning, sequence analysis, and involvement of the ERCC-3 gene in XP ant: CS.
Results
Cloning of ERCC-3 cDNA The human excision repair gene ERCC-3 was cloned after DNA-mediated gene transfer of HeLa chromosomal DNA into the UV-sensitive CHO mutant 27-1, a member of complementation group 3 (generously provided by Dr. R. D. Wood, ICRF, London) (Weeda et al., 1990) . Mutants of this group are very sensitive to UV irradiation and to agents inducing bulky adducts; they have reduced DNA repair synthesis and harbor a defect in one of the steps preceding the incision of damaged DNA. These characteristics strongly resemble those of cells from XP patients, Unique ERCC-3 genomic sequences were used as probes to isolate the ERCC-3 cDNA from various human cDNA libraries (see Experimental Procedures and Weeda et al., 1990, for details) . The physical maps of the four cDNA clones discussed in the present article are depicted in Figure 1 . The insert size of pCD1 (-2.8 kb) is very close to the size of ERCC-3 mRNA (2.9 kb), suggesting that this cDNA is (close to) full-length. Furthermore, transfection of ERCC-3 cDNA clones pCD1 and pH3T or pHK1 inserted in mammalian expression vectors conferred wild-type UV survival and repair synthesis to 27-l cells with a very high efficiency (Weeda et al., 1990) . Plasmids pCD2 and pH3T1, with shorter inserts, were unable to induce a repair-proficient phenotype, suggesting that they are incomplete.
Nucleotide
Sequence of ERCC-3 cDNA The nucleotide sequence and the deduced amino acid sequence of pCD1 and pHT1 are shown in Figure 2 . The first ATG (position 40) starts an open reading frame (ORF) of only 48 bp, whereas the second ATG (position 98) is followed by an ORF of 2346 bp. Although in more than 95% of all mRNAs known the first ATG serves as the start codon for translation (Kozak, 1984) we believe that in the case of ERCC-3 the second ATG represents the actual translation initiation site of the ERCC-3 protein. This proposition is based on the following observations, First, the purine residue found at the -3 position of most eukaryotic start codons (Kozak, 1984) is not present in front of the first ATG (in contrast to the second ATG; Figure 2A ). In other examples where the 5' ATG is in an unfavorable context for initiation (i.e., position -3 not A/G, position +4 not G), "leaky scanning" has been observed, which enables some ribosomes to reach and initiate at the more favorable second ATG (Kozak, 1989) . Second, a data base search of protein coding regions based on codon preference (Staden and McLachlan, 1982) gave a strong bias in favor of the second, long ORF. Third, the first ATG is absent from the 5' leader of the functional mouse ERCC-3 cDNA (unpublished data). Finally, we found a shorter human cDNA clone (pHK1) that lacks the first ATG but still confers wild-type UV resistance to 27-1 cells. Notably, the human ERCC-2 gene harbors ATG codons in its 5' untranslated region as well (Weber et al., 1990) . Inspection of the 3' region revealed the sequence of the common polyadenylation signal (Wickens and Stephenson, 1984) at 29 bp before the start of the poly(A) tail. The pentanucleotide sequence CAYTG, which is found adjacent to the polyadenylation site in many eukaryotic genes (Berget, 1984 ) is also present. A group of AU-rich sequences (AUUUA) in the 3' noncoding region of many short-lived mRNAs associated with metabolic instability (Shaw and Kamen, 1986) can be detected in the 3' noncoding region of ERCC-3 ( Figure 2A ).
Sequence of ERCC-3 Protein and Homology with Other Proteins and Functional
Domains The deduced amino acid sequence of the ERCC-3 cDNA predicts a protein of 782 amino acids, with a calculated molecular mass of 89,274 kd. To determine whether the ERCC-3 gene product shows sequence similarity with other polypeptides, a FASTA computer search was performed. No strongly homologous proteins were found with published sequences available in various data bases. A systematic search for functional domains present in the predicted amino acid sequence of ERCC-3 yielded the following regions of interest:
First, there is a potential nuclear localization signal at amino acid positions 6-18. A stretch of basic amino acids has been identified in several proteins involved in mediating transport to the nucleus (see Roberts, 1989 , for a recent review). In Figure 2C the amino acid sequence of part of the ERCC-3 protein is compared with a number of known and presumed nuclear localization signals in other proteins. The motif KKlRXKlR has emerged as a common (but not exclusive) feature in many nuclear localization sequences described to date and is found in the exposed N-terminal part of ERCC-3.
Second, there are several regions with a pronounced negative charge (amino acids 20-29, 256-265, 697-701, and 721-728) . Stretches of acidic amino acids have been found in a number of proteins that associate with chromatin and/or histones such as the high mobility group I family (Wen et al., 1989) transcription factors (for a review see Ptashne, 1988 ) nucleolin (Lapeyre et al., 1987 and the histone 2A/2B-specific ubiquitin-conjugating enzyme RAD6 (Jentsch et al., 1987) . The negatively charged amino acids are thought to permit electrostatic interaction with the basic histones. The presence of such modules in ERCC-3 suggests that it has the capacity to associate with chromatin.
Third, there is a potential DNA binding motif at amino acids 121-142. In Figure 2D the amino acid sequence of this part is compared with a number of known or presumed "helix-turn-helix" DNA binding domains. This motif is one of the most extensively investigated DNA binding domains identified in a number of prokaryotic and eukaryotic proteins, including prokaryotic repressors, yeast mating type regulatory proteins, and homeobox proteins (for reviews see Pabo and Sauer, 1984; Struhl, 1989) . ERCC-3 contains the correct amino acids at the position considered to be crucial for the configuration of the two helices, consistent with the idea that this part may be involved in DNA binding.
Fourth, inspection of the ERCC-3 main ORF revealed the "A" site of the NTP binding sequence typical of numerous enzymes utilizing ATP and GTP (Walker et al., 1982) . Alignment with the nucleotide binding site of the yeast ssDNA-dependent ATPase RAD3, which possesses DNA helicase activity, and with the consensus sequence deduced from many ATPases is shown in Figure 2E , domain I. Furthermore, a segment corresponding to the "6" site of NTP binding domains, which is thought to interact with the Mg2+ cation of Mg-NTP through the conserved D residue (de Vos et al., 1988) is readily recognized in the ERCC-3 amino acid sequence (segment II in Figure 2E) . Fifth, the 'A" nucleotide binding site starts with a region exhibiting a virtually perfect match with seven consecutive domains recently recognized by several investigators to be conserved between two superfamilies of known and putative DNA and RNA helicases (Hodgman, 1988; Gorbalenya et al., 1988 Gorbalenya et al., , 1989 Linder et al., 1989) . The deduced consensus sequence of each module and the cor- responding sequence of the yeast repair helicase RAD3 are compared with that of ERCC-3 in Figure 2E . It is evident that ERCC-3 matches overall better to the consensus than RAD3. Some ERCC-3 domains display-apart from the consensus residues-extensive additional similarity to RAD3 (e.g., domains I, IA, III, and particularly VI, of which 10 of the 17 residues are identical). The remaining portions of the two proteins are, however, very different. The presence of all motifs, their proper positioning, and their high level of homology to the consensus sequence provide strong evidence for a potential DNA unwinding function of ERCC-3.
These data taken together suggest that the ERCC-3 gene encodes a nuclear, DNA and chromatin binding helicase, with a well-organized overall structure; its central part starts with the nucleotide binding domain, encoding a DNA unwinding function, which is preceded by a DNA binding motif and a nuclear localization sequence, and which is flanked by acidic regions that enable the protein to interact with (basic) histones (Figure 28 ). However, definite proof for these properties awaits functional analysis of the protein.
Role of ERCC3 in XP Since the repair phenotype of rodent group 3 mutants resembles that of XP cells in many aspects, it was of interest to examine whether ERCC-3 is involved in this human disorder. To answer that question, a systematic analysis was performed at the DNA, RNA, and functional levels. Madura and Prakash, 1986) and FtAD78 (Jones et al., 1988) , poly(ADP-ribose) polymerase (Cherney et al., 1967) , nucleoplasmin, and S. cerevisiae histone H2B. A consensus sequence for nuclear localization signals has been described by Roberts (1989) , where references for other sequences can be found. Identical (solid line) or similar (dashed line) residues shared by all proteins are boxed. Nuclear localization signal functions that have not been demonstrated are indicated with an asterisk. (D) Amino acid comparison of ERCC-3 and ERCC-1 and DNA binding domains in Drosophila fushi tarazu (FTZ) homeobox proteins (Shepherd et al.. 1984) and in prokaryotic activator and repressor proteins A. cro, ?. cll, and P22 cro (reviewed in Pabo and Sauer, 1984) . See van Duin et al. (1986) for the ERCC-7 sequence.
Amino acids 6, 9-11, and 16, which are important for proper positioning of the two a helices with respect to each other, are boxed. Positions of the two CI helices of the DNA binding domain are shown at the bottom. Amino acids are numbered, and those identical with the fRCC3 sequences are underlined. (E) Homology between the amino acid sequences of ERCC-3 and RAD3 and seven conserved motifs of two superfamilies of more then 20 known DNA and RNA helicases (Gorbalenya et al., 1988 (Gorbalenya et al., , 1989 . Identical (solid underline) or strongly homologous (dashed underline) residues shared by the RAD3 and ERCC-3 proteins are indicated. cells. Other enzymes yielded similar results, confirming the absence of major structural abnormalities (data not shown).
Second, to investigate the expression of the endogenous ERCC3 gene in a number of XP cell types, total RNA was isolated and analyzed by Northern blot experiments using ERCC-3 cDNA as a probe (Figure 38 ). All eight XP groups examined produced comparable amounts of an ERCC-3 transcript of the correct length. From these data we conclude that the ERCC-3 gene in the XP cells tested contains neither mutations affecting the size of the mRNA nor drastically reduced levels of the transcript.
These data do not exclude the possibility that the ERCC-3 gene is inactivated by a small (point) mutation that impairs its function. To investigate this possibility, functional complementation studies were performed. The ERCC-3 cDNA expression clone pCD1, driven by the SV40 early promoter (Okayama and Berg, 1982) , was cotransfected with the dominant selectable marker pRSVneo into SV40-immortalized XP fibroblasts that are available for six of the XP complementation groups: XP-A, XP-C, XP-D, XP-E, XP-F, and XP-G (see Experimental Procedures). The G418-resistant transformants of each line were grown in mass culture consisting of 20 to more than 100 independent clones. Given the relatively poor transfection properties of many SV40-immortalized human fibroblast lines (Hoeijmakers et al., 1987) , we confirmed by Southern and Northern blot analysis that the transfected cDNA was incorporated and properly expressed by a considerable fraction of the transformants in each of the XP lines (results not shown; see equivalent results for ERCC-7 in van Duin et al., 1989) . To test whether ERCC-3 restores the DNA repair characteristics, we determined the UV survival of G418-resistant mass populations. All six transformed XP cultures displayed mutant UV survival phenotypes, indicating inability of ERCC-3 to correct their defects (not shown).
The remaining two XP complementation groups (XP-B and XP-H, both associated with CS), for which no immortalized cell lines suitable for transfection experiments are available, were examined for ERCC3 correction by means of microinjection.
The ERCC-3 cDNA construct used above was injected into one of the nuclei of XP homopolykaryons generated by cell fusion of the XP fibroblasts (see Experimental Procedures). To assay for the ability of the injected ERCC-3 cDNA to correct the excision defect in these XP complementation groups, injected cells were probed for their capacity to perform UV-induced unscheduled DNA synthesis (UDS). To allow expression of the injected gene copies, 18-24 hr after injection the fibroblasts were exposed to UV light (16 J/m2), incubated in the presence of [3H]TdR (2 hr), and processed for autoradiography to visualize incorporation of [3]HTdR in repair patches. Noninjected cells were subjected to the same procedure. The untreated XP-B (XPllBE) fibroblasts characteristically showed a strongly reduced level of UDS, indicated by a low number of autoradiography grains above their nuclei ( Figure 4 , noninjected cells; see also Table 1 ). The XP-H fibroblasts displayed a considerable residual UDS. As shown in Figure 4A and Table 1 (experiments I and IV), injection of ERCC-3 cDNA did clearly restore UDS in the XPll BE homopolykaryons to wild-type levels and had no effect on UDS of the XP-H cells.
Several control experiments were carried out to validate this finding. The specificity of the correction was established by injection of E/KC-3 cDNA into fibroblasts of other XP complementation groups. No correction was found in XP-G or XP-D cells, in agreement with the transfection results (data not shown). On the other hand, injection of ERCC-7 cDNA or of an incomplete and inactive ERCC-3 cDNA construct (pCD2) into XPIIBE did not significantly enhance the UDS in XPllBE (Table 1; van Duin et al., 1989) . Furthermore, when UV irradiation was omitted, no increase in the number of grains was observed, ruling out the possibility that the grains were due to damage-independent DNA synthesis. The XPilBE correction is very powerful. Dilution experiments demonstrated that injection of a single ERCC-3 cDNA molecule into one of the nuclei of a homopolykaryon still induced wild-type UDS in all nuclei of the injected cell (not shown). Finally, cytoplasmic injection of in vitro synthesized ERCC-3 RNA transcribed from the PEP-1 construct (a ERCC-3 cDNA plasmid containing the SP8 promoter; see Experimental Procedures) also enhanced UV-induced UDS of XP-B fibroblasts (Table 1 , experiment Ill). We conclude that func- tional ERCC-3 cDNA very specifically and efficiently corrects the excision repair defect in XPllBE, strongly suggesting that the ERCC-3 gene is the defective gene in this XP/CS complementation group.
Determination of the ERCC-3 Mutation in XPllBE Cells
Since the ERCC-3 gene is not detectably rearranged in XPllBE and its RNA is properly expressed (see Figure 3) it is most likely inactivated by a small-scale mutation. To search for such a mutation, we utilized the polymerase chain reaction (PCR; Saiki et al., 1988) to amplify cDNA from mRNA of cells (fibroblasts and lymphoblastoid lines) from the sole XP-B patient (XPllBE) and her mother. Since the ERCC-3 transcript is too large and too rare to be amplified in one step, its mRNA was amplified in three segments: 5' (706 bp), central (899 bp), and 3' (1219 bp). Sequence analysis revealed that the 3'section of the patients cDNA had incurred a 4 bp (GCAG) insertion at position 2220, disturbing the ORF ( Figure 5 ). No changes were observed in the remainder of the XPllBE cell ERCC9The deviation from the normal sequence was found in all eight independent cDNA clones of XPllBE sequenced.
To determine whether this mutation is inherited, the relevant part of the cDNA of the patient and her mother (no cells of the father are available) were amplified and subjected together with cDNA from HeLa cells to dot blot analysis. The filters were hybridized with 32P-labeled oligonucleotides specific for the wild-type and mutant genes ( Figure 6 ). As an internal control on the quality of the RNA, cDNA synthesis, and amplification, amplimers specific for the N-ras oncogene were included in the reaction. The specificity of the hybridization was tested using the cloned wild-type and mutated ERCC-3 cDNA spotted on the same filter. Hybridization of the N-ras probe demonstrates that all RNAs gave amplification of the N-MS transcripts (Figure 6C) . As expected, the HeLa control displays only hybridization to the wild-type-specific ERCC-3 oligonucleotide probe ( Figures 6A and 6B) . RNA of the patient shows clear hybridization with the mutant-specific probe ( Figure  6B ) and hardly any signal with the wild-type-specific probe (note that this probe gives a weak cross-hybridization to the mutant ERCC-3 cDNA; Figure 6E , right). The RNA from the mother, however, exhibits clear hybridization with both probes (Figures 6A and 6B ). This indicates that she is heterozygous for the mutation in the ERCC-3 gene and that the patient inherited this insertion from her mother. The sequence analysis of cDNA clones, the dot blot hybridization, and Si nuclease analysis (not shown) indicate that most, if not all, ERCC-3 transcripts in the XPllBE cells carry the 4 bp insertion.
Mutation at the Genome Level Is a C-A Transversion in a Splice Acceptor Site What is the molecular mechanism responsible for the insertion of the GCAG sequence at the mRNA level? The last 3 bases of the insertion correspond to the consensus sequence for splice acceptor sites (CAG) found at the end of introns. This suggested that improper splicing might account for the alteration at the level of mature ERCC-3 mRNA. To resolve the genetic basis of the mutation and to see whether the patient is heterozygous for it, we examined the ERCC-3 gene in XPllBE and HeLa chromosomal DNA. The genomic organization of ERCC-3 has been elucidated for the most part. Unfortunately, the portion of the gene in which the mutation resides has so far been refractory to cloning in E. coli: we have not been able to subclone it from cosmid and h libraries covering >60 human genomic equivalents (Weeda et al., 1990) .
We therefore decided to amplify the genomic region surrounding the mutation by PCR with the help of the flanking primers p34 and p39 (see Figure 1 ). This yielded several clones from both the XPllBE and HeLa genomic DNA. Sequence analysis of the HeLa (wild-type) ERCC-3 gene between the primers revealed the presence of a splice acceptor site exactly at the position of the mutation in XPllBE transcripts ( Figure 5 ). In the XPllBE DNA two sequences were found: one identical with the wild-type sequence, the other containing a C-A transversion at a position that creates a new splice acceptor site consensus sequence 4 bp upstream of the one used in the wild-type situation. This is expected to shift the intron/exon border 4 bp into the intron, resulting in the incorporation of an additional 4 bp into the adjacent exon. The first allele must represent the paternal gene copy, the second that origi- See Figure 16 for amplification strategy. Amplified DNA from HeLa cells, XPllBE, and GM1655 (mother of XPllBE) was spotted onto Biotrace nylon filters and hybridized with a labeled wild-type oligonucleotide probe (p42; A and E) or a mutant oligonucleotide probe (~43; B and F) (see Experimental Procedures for primer sequences).
To ensure that the samples are equally capable of undergoing amplification of specific sequences by the PCR method, amplimers specific for the N-ras gene (around codon 12) were also added to the cDNA mix and hybridized to an N-ras 12-specific oligonucleotide probe (C). To confirm that equal amounts of amplified material were spotted onto the filter, the filter was hybridized with an ERCC-Sspecific oligonucleotide (~12; D). As a control for the specificity of hybridization of mutant and wild-type ERCC-S-specific oligonucleotides, plasmid DNA from clones pSVH3 (wild type) and pSVH3M (XP-B mutation) was spotted in serial dilution (E and F). Note that the wild-type-specific ERCC-3 oligonucleotide probe (~42) weakly cross-hybridizes to the mutant cDNA in pSVH3M (E, right).
nating from the mother. The sequence predicts that in the mutant ERCC-3 allele there should be a BstNl restriction site at this position and none in the paternal allele.
To confirm the results described above, we subjected chromosomal DNA of XPllBE and her mother to BstNl restriction digestion (Figure 7 ) and performed Southern blot analysis using a 3Wabeled probe that recognizes only the last exon. As anticipated, BstNl degraded approximately 50% of the wild-type fragment from the patient and her mother. Collectively, these results imply that the patient and her mother are both heterozygous for a splice mutation inactivating one ERCC-3 allele, and that the paternal allele in the patient must contain another small mutation causing the ERCC-3 mRNA derived from this gene copy to be absent or greatly reduced.
XP Mutation Inactivates the ERCC-3 Repair Function
The extra 4 bp present in the ERCC-3 mRNA of XPllBE causes a frameshift starting at codon 740. To determine the effect of this C-terminal mutation on E/WC-3 function, a cDNA construct (pSVH3M) carrying the 4 bp insertion was made and was microinjected into XPllBE fibroblasts. No significant enhancement of UDS was found even at cDNA concentrations lOO-fold higher than required for the normal cDNA to yield wild-type correction ( Figure 48 and Table 1 ). Furthermore, transfection of pSVH3M into the CHO mutant 27-l failed to increase the UV survival of this rodent repair mutant (not shown). These experiments indicate that the XPllBE mutation inactivates the ERCC-3 repair function, as evidenced by its inability to correct the UV survival of 27-1 cells and the UDS of XPllBE itself.
Discussion
This paper identifies the molecular defect in a human DNA repair disorder. A C+A transversion in the excision repair gene ERCCJ was shown to underlie the inborn defect in XP complementation group B, a complex and remarkable conjunction of xeroderma pigmentosum and Cockayne's syndrome. The gene that we hence designate XP-B-correcting (XPBC)/ERCC-3 is predicted to encode a DNA repair helicase. In addition, this study reveals an overlap between the class of rodent mutants and naturally occurring human inborn defects of DNA repair. This finding demonstrates the importance of the rodent repair mutants as a model for human repair disorders.
Combination
of XP and CS XPllBE, the sole patient representing XP-B, was the only affected child in a family consisting of seven daughters of unrelated parents. She remains remarkable as she clearly manifests the clinical symptoms of two rare excision repair disorders: CS (sensitivity to sunlight, dwarfism, microcephaly, wizened facial appearance, deafness, severe mental retardation) and XP (extreme sensitivity to sunlight, pigmentation abnormalities, predisposition to skin cancer [the latter two are not normally associated with CS]) (Cleaver and Kraemer, 1989) . The patient's cellular defects include hypersensitivity to UV light and virtually complete absence of excision repair as measured by the level of UV-induced UDS (which also is unusual for CS) (Lehmann, 1987) . At the biochemical level, CS cells are thought to be disturbed in the preferential repair of actively transcribed genes, their overall genome repair being normal (Venema et al., 1990b) . XP patients harbor deficiencies affecting both processes or, in the case of XP-C, only the "global" genome repair subpathway (Venema et al., 1990a) .
In view of the extreme rarity of both disorders (of the order of 10e5 each), it is highly unlikely on statistical grounds that XPllBE represents a double mutation affecting two distinct genes. In this patient's family no siblings suffering from either of the syndromes have occurred, nor has any patient been identified that falls into the same complementation group and shows the clinical features of only one of the diseases. However, the possibility that two closely linked loci are involved, both of which are inactivated by one deletion, cannot be dismissed on the basis of these arguments. The Southern and Northern blots and sequence analysis data, as well as the microinjection results presented here, indicate that the XPBCIERCC-3 gene fully and specifically corrects the repair defect in XP-B and that it is inactivated by small-scale mutations. This rules out the involvement of additional genes by way of gross gene rearrangements.
Hence, the XPBCIERCC-3 protein is either implicated in two excision repair subpathways, one associated with XP and the other with CS, ormore likely-participates in a common step leading to the phenotypic features of both disorders (Lehmann, 1987) . Since inactivation of XPBCIERCC-3 results in predisposition to skin cancer, the gene can functionally be considered a tumor-preventing gene.
The Mutation in the XPBCIERCC-3 Gene Analysis of the XPBCIERCC-3 gene in the XPllBE patient's chromosomal DNA revealed that her maternal allele harbored a C-+A transversion in the last intron, generating an optimal splice acceptor sequence 4 bp upstream of the normal 3' splice site. In vitro experiments have indicated that the spliceosome complex scans for the first AG dinucleotide located 3' of the branchpoint and a polypyrimidine tract (Smith et al., 1989) . In some instances where a series of closely spaced AG sequences occur, subsequent AGs may occasionally also be interpreted as the start of the next exon. Nevertheless, in these instances the first AG is the one predominantly used (Fu et al., 1988) . Sequence analysis of PCR-generated XPBCl ERCC3 cDNA clones of XPllBE RNA and dot blot data demonstrate that the vast majority, if not all, of the XPBCI ERCC-3 transcripts contain the intron-derived 4 bp insert and, therefore, used the first (C)AG.
These results provide an in vivo confirmation of the above findings with the in vitro splicing studies based on nuclear extracts. Our data agree with those for the behavior of a number of splicing mutants in other inherited disorders in which new coding segments are inserted or in which protein function is disrupted by in-frame insertion (Nakano and Suzuki, 1989) or by frameshifting of the normal exon sequences (Spritz et al., 1981; Metherall et al., 1986) . The parents of XPllBE are unrelated; hence it is not unexpected that the patient appeared to be heterozygous for the splice mutation. Since we failed unequivocally to detect transcripts without the 4 bp insertion, we must presume that the paternal allele is not detectably expressed at the level of mature XPBCIERCC-3 mRNA. This may be due to a mutation affecting either the promoter of the gene or the processing, transport, or stability of its transcript.
The DNA Repair Defect in XPllBE Although XPllBE fibroblasts have a greatly reduced level of repair synthesis, they still display detectable UDS (see Table 1 ). This low residual activity may be explained in various ways. First, we cannot completely rule out the possibility that a small amount-too low to be detected by our techniques-of functional XPBCIERCC-3 transcript is synthesized. Such RNA could be derived from the paternal allele, or, if its origin is maternal, it could still be a rare, correctly spliced molecule. Second, it is possible that the mutated XPBCIERCC-3 gene product still fulfills part of its functions or displays a dose-independent, severely decreased activity. In this respect it is worth noting that the frameshift affects only the C-terminal 41 amino acids of the predicted XPBCIERCC-3 protein, a region as yet devoid of assigned functional domains. Finally, it can be envisaged that the residual UDS originates from other repair processes or from excision repair subpathways that are not completely blocked by the lack of functional XPBCI ERCC-3 protein. Further investigations are required to discriminate between these alternatives.
The Presumed Helicase Function of XPBC/ERCC9 Systematic comparison of the predicted amino acid sequence of the XPBCIERCC-3 gene product with known functional domains in other proteins suggests that it may be a DNA, chromatin, and nucleotide binding helicase. The deduced protein bears a striking resemblance (almost perfect match and proper spacing) to seven consecutive amino acid motifs identified in two related superfamilies of putative or already established helicases. The set of helicase domains invariably starts with a nucleotide binding region. In addition, we have identified a stretch with structural homology to "helix-turn-helix" DNA binding motifs and to various very acidic domains encountered, e.g., in the high mobility group I protein family, which is thought to carry the ability to associate with basic histones in chromatin (Reeck et al., 1982) .
Since DNA unwinding constitutes a key step in the initi-ation of many processes of nucleic acid metabolism, it is not surprising that helicases are increasingly recognized to be important for many fundamental cellular systems. Thus members of this rapidly expanding family of proteins are implicated in the initiation and progression of DNA replication (Brill and Stillman, 1989) and transcription (Sopata et al., 1989) , as well as cell proliferation (Ford et al., 1988; Hayet al., 1988 ), splicing (Sbraphin et al., 1989 , ribosome assembly (Nishi et al., 1988) , and initiation of translation (Abramson et al., 1987) . Furthermore, these enzymes play a central role in DNA recombination (e.g., Kodahek and Alberts, 1987) and repair. In E. coli the uvrAB complex has been shown to exhibit DNA helicase activity, which is used for scanning of the DNA for structural perturbations and/or local unwinding of the DNA strands at the site of the lesion (Oh and Grossman, 1987) . At later stages, when the uvrC endonuclease has introduced two scissions into the damaged strand, the uvrD protein (i.e., helicase II, a3 '--5'unwinding protein) is involved in the release of the lesion-containing oligonucleotide from the DNA (Matson, 1988; see Sancar and Sancar, 1988 , for a review). coworkers (1987a, 1987b) have demonstrated that the yeast excision repair protein RAD3 also encodes an ATP-dependent (5'+3') DNA helicase. Interestingly, Weber et al. (1990) have found recently that the predicted human excision repair protein ERCC-2 harbors a >,50% overall sequence similarity to the RAD3 polypeptide. This implies that ERCC-2 is the human equivalent of yeast RAD3. All essential amino acids in the seven helicase domains are strongly conserved between the yeast and human proteins, suggesting that the human gene product may also be a 5'-+3' DNA helicase.
Our findings identify a second putative DNA unwinding protein in mammalian excision repair. It is tempting to speculate that the ERCC-2 and XPBCIERCC-3 proteins may fulfill closely associated, equivalent, or complementary functions. This is consistent with the fact that the phenotypes of mutant rodent groups 2 and 3 are very similar: both have a similar degree of sensitivity to UV and agents causing bulky DNA adducts, no pronounced crosssensitivity toward X-rays and DNA cross-linking agents such as mitomycin C, a similar level of UV-induced mutagenesis, and a defect in early (pre)incision steps of the excision repair pathway (Thompson et al., 1980 (Thompson et al., , 1982 Thompson, 1989; Zdzienicka and Simons, 1987; Zdzienicka et al., 1987) . Furthermore, we have identified a yeast homolog of XPBCIERCC-3 that exhibits a level of amino acid similarity to XPBC as high as that found between the ERCC-2 and RAD3 proteins (Koken, Weeda, and Hoeijmakers, unpublished data).
These considerations are consistent with the hypothesis that ERCC-2 and XPBCIERCC-3 exert a similar function. An obvious possibility is that the XPBCIERCC-3 protein unwinds DNA in the direction opposite (3'+5') to that of the RAD34ype helicase (e.g., ERCC-2) and that both work together in locally unwinding the duplex DNA on both sides of the lesion, as indicated in the model of Figure 8. Alternatively, it is possible that the two enzymes cooperate in scanning long stretches of DNA for structural distortions or in ridding the DNA around the lesion of nucleosomes, to give repair complexes access to the site of the DNA injury.
One final point concerns another important function of the RAD3 gene, and presumably the ERCC-2 gene as well. Null alleles of RAD3 generated by gene disruption or point mutations appear to be recessively lethal, indicating an essential role for RAD3 in yeast cell viability (Higgins et al., 1983; Naumovski and Friedberg, 1983) . The notably low recovery of group 2 (ERCC-2) rodent mutants as the result of mutagenesis with mutagens that cause mainly frameshifts as compared with agents that induce predominantly point mutations strongly suggests that frameshifts in the ERCC-Pgene tend to be lethal in the hamster as well (Busch et al., 1989) . It could be that the XPBCIERCC-3 gene, by analogy with ERCC-2 and RAD3, has a vital function in addition to its role in DNA excision repair. The proposition that only those mutations in the XPBCIERCC-3 gene are tolerated that leave its vital function intact could explain the extreme rarity of this type of inborn defect and our finding that the mutation in the expressed allele is situated in the very C-terminal part, outside of the regions to which we have assigned specific functions. The issue of whether XPBCIERCC-3 has an essential role in cell viability can be more easily addressed in the yeast system, and these experiments are currently under way.
Experimental Procedures
General Procedures Purification of nucleic acids, restriction enzyme digestion, gel electrophoresis, nick translation, and filter hybridization were performed according to established procedures (Maniatis et al., 1982) .
Cell Lines and l?ansfection Experiments UV-sensitive 27-1 ceils (Wood and Burki, 1982) were cultured in FlOIDuibecco's minimal essential medium (DMEM) supplemented with 5% newborn calf serum and 5% fetal calf serum (GIBCO). 100 pglmi streptomycin, and 100 U/ml penicillin. XP fibrobiasts were cultured in FIO supplemented with 10% fetal calf serum. Transformed ceil lines harboring the E. coii gpfdominant marker gene were selected and cuitured in XGPT medium containing FlO/DMEM as described above supplemented with 0.2 pglml aminopterin, 5 pg/ml thymidine, 10 pg/ml xanthine, 25 pglmi mycophenolic acid (GIBCO), 15 pglml hypoxanthine, and 2.3 vglmi deoxycytidine.
Cell lines containing the selectable -b-l-6 Figure 8 . Model for the Action of Repair HeliEyr&air helicases E-2 and XPBCLERCC3 (hatched) are proposed to work together to unwind the duplex DNA at both sites of the lesion in an early preincision step of the excision repair pathway. marker aminoglycosyl phosphotransferase were selected wrth the antibiotic G416 (100-400 pglml, depending on the cell line). The selection medium was refreshed every 3-5 days. Transfection of 27-1 and SV40-immortalized XP fibroblasts was performed essentially as described by Graham and van der Eb (1973) . XP cells were transfected at 80% confluence with 1 pg of pRSVneo plus 2 pg of the ERCC-3 expression plasmid pCD1; 27-I cells were transfected with 1 pg of pSV3gptH (Westerveld et al., 1984) plus 2 hg of pCD1. After transfection the cells were shocked in 5 ml of PBS containing 10% dimethyl sulfoxide for l-2 min, and rinsed twice with 10 ml of PBS. The medium was refreshed 48 hr after transfection by medium containing 100-400 Kg/ml G418 (GIBCO) or XGPT medium. Selection for repair-proficient transformants was done as follows: after the appearance of mycophenolic acid-or G418-resistant colonies, each dish was trypsinized and the cells were reseeded into two dishes and irradiated with 254 nm (peak) germicidal UV light at a flux of 0.5 J/m". Cells were irradiated three times with 4.5 J/m2 UV light at 1 day intervals. For the primary and SV40-transformed XP fibroblasts lines used in this study, see van Duin et al. (1989) cDNA constructs pCD1 and pCDP, with or without addition of pSV3gpt in a 1:l molar ratio (0.5 Kg/ml, final concentration), were injected into the nuclei of XP homopolykaryons as described by van Duin et al. (1989) using procedures previously described (de Jonge et al., 1983) . Cells were incubated for 24-46 hr to allow expression of the injected DNA. To assess the success rate of injection, one part of the injected cells (in the coinjection experiments) was stained for the expression of SV40 large T antigen encoded by pSV3gpt, using a monoclonal antibody and a fluorescein isothiocyanate-containing goat antimouse conjugate. To determine the effect on the repair potential, the other part of the injected cells was subjected to UV-induced UDS, which was measured by autoradiography as described previously (Vermeulen et al., 1986) . In vitro synthesized RNA was injected into the cytoplasm, and the cells were assayed for UDS 6-20 hr after injection.
Southern
Blot Analysis Restriction endonuclease digestions were carried out as recommended by the manufacturer (Pharmacia). Chromosomal DNA (15 hg) was size fractionated by gel electrophoresis on a 0.8% agarose gel. After alkaline treatment the DNA was blotted onto nylon filters (Biotrace) according to the suppliers instructions. Probes were labeled by nick translation.
RNA Isolation
and Northern Blot Analysis Total RNA was isolated by the LiCI-urea method described by Auffray and Rougeon (1980) . Cytoplasmic RNA was isolated by the NP40 method as described in Maniatis et al. (1962) . RNA samples were separated by electrophoresis through a 1% agarose-formaldehyde gel and transferred onto nitrocellulose. The filters were hybridized at 42°C in formamide (50% [v/v] ), 5x SSPE, 5x Denhardt's solution, 1% SDS, and 100 mg/ml denatured salmon sperm DNA. The filters were hybridized with a 32P-labeled nick-translated probe. Filters were washed two times with 2x SSC containing 0.1% SDS at 60% Isolation of cDNA Clones and Sequencing The 1.5 kb Pstl insert fragment of pCD1 was used as a probe for isolating other cDNA clones of human origin. To this end, a SgtlO human testis cDNA library (Clone Tech) and a cDNA library of human chronic myelogenous leukemia cell line K562 were screened. Positive 1 clones HT3 and HKl were subcloned into M13mp18 or M13mp19 vectors, respectively, for sequence analysis by the dideoxy chain termination method (Sanger et al., 1977) with Sequenase (United States Biochemrcal Corp.) and Ml3 or sequence-specific primers, or cloned into appropriate expression vectors to yield pH3T, pHST1, and pHK1, respectively. Sequences were analyzed and compared using the Wisconsin software and the FASTA program.
DNA Amplification
and Mutation Detection Total or cytoplasmic RNA (10 frg) was used for preparing cDNA with ERCC-B-specific primers (see below). RNA was dissolved in 9 ul of annealing buffer (250 mM KCI, 10 mM Tris-HCI [pH 6.31, 1 mM EDTA]). Following the addition of 1 ul (100 pmollpl) of primers, the samples were first heated for 3 min at 80% and transferred to a 37% water bath for 1 hr, 15 frl of cDNA buffer (24 mM Tris-HCI [pH 8.31, 16 mM MgCIz, 8 mM DTT, 0.4 mM of dGTR dATP, dTTR and dCTP) and 5 U of Moloney murine leukemia virus reverse transcriptase (Promega) were added, and the tubes were incubated at 37% for 1 hr. To 5 PI of cDNA, 10 &I of Taq buffer (100 mM I-is-HCI [pf-l 8.31, 15 mM MgClz, 500 mM KCI, 2 mglml BSA), 4 pl of dNTPs (2.5 mM), 75 rrl of sterile water, 1 pl (100 pmollrrl) of each primer, and 2 U of Taq polymerase (Cetus) were added. Amplification was performed by 32 consecutive cycles of 1 min at 95'C, 1 min annealing at 50°C and 3 min of extension at 70% as described by Saiki et al. (1985) . Chromosomal DNA was amplified as described above. Amplified DNA was spotted onto Nylon (Biotrace) filters, UV cross-linked, and hybridized to wild-type and mutant 32P-labeled primers. As an internal control, the N-ras allele around codon position 12 was amplified from the same RNA sample, as described by Verlaan-de Vries et al. (1986) . The amplified DNA was purified and digested with the appropriate enzyme or treated with mung bean exonuclease as indicated in Figure 5 and subsequently cloned into M13mp18 or M13mp19 vectors.
Oligonucleotide primers for cDNA, DNA amplification, and DNA sequencing were synthesized in an Applied Biosystems DNA synthesizer. The PCR primers used in this study are described below:
~12: 5'-GGGTGTACATGTTTGC-3' ~33: 5'-GGATCCACCATGGGCAAAAGAGACCG-3 ~34: 5'-GCGCAAGCTTACTGGTTCAATGGTCCATTC-3 ~35: 5'.CTGATTGGGCCTAAGCTCTAC-3' ~36: 5'-CCTCAGCACACTGGACTTTG-3 ~37: 5'-GCGCGAATTCGGATTGAGCCGGAAGTCCCC-3' p39: 5'-GCGGATCCTGATCACGAAACTCGCTG-3' ~40: 5'-GGGAGGCCACTGAGCTCATC-3' ~41: 5'CGGGAAGTGGAGGGCCCACC-3 ~42: 5'~CCGAGATGCCTGGCTGGA-3' ~43: 5'7GAGATGCCTGCCTGGCTG-3 ~44: 5'-GACATAGAACTCATGGTGCC-3 ~45: 5'-GGTGGTGGCTGGGGAATTTG-3' ~55: 5'-GACTAACATGGGCTGGTTCC-3
In Vitro Transcription RNA was synthesized in a 100 frl reaction in whrch 2 rrg of linearized substrate DNA was incubated for 1 hr at 3PC with SP6 RNA polymerase in the presence of RNasin (Promega).
The RNA was purified and ethanol precipitated.
The RNA was capped as recommended by Promega. After purification, it was microinjected into the cytoplasm of homopolykaryons of XP-B fibroblasts and the effect on induced UDS determined, as described above.
Plasmids
The plasmid used in the study for synthesizing RNA was constructed as follows: pCD1 was used to mutate the -3 position (G-A) in front of the translation initiation codon by PCR, using an oligonucleotide primer containing a BamHl restriction site (using the oligonucleotide primer ~33). The 2.7 kb BamHl cDNA insert of pCD1 (containing a poly[A] tract) was cloned into pSP65, yielding pEP1. The cDNA expression plasmids for microinjection were constructed as follows: pSVH3 contains the 5' 1.5 kb EcoRI-Pstl fragment of the ORF of pH3Tl ligated together with the 3'1.2 kb Pstl-Hindlll fragment of pHK1 into a modified pSVL eukaryotic expression vector (Pharmacia). In pSVHSM, the 3' part was replaced by a 1.2 kb Pstl-Hindlll fragment synthesized by means of amplifying XP-B cDNA (with oligonucleotide primers ~34 and P35).
